Zobrazeno 1 - 10
of 85
pro vyhledávání: '"Steffen M Jugl"'
Autor:
Atul Deodhar, Vibeke Strand, Rieke Alten, P G Conaghan, Emma Sullivan, Stuart Blackburn, Haijun Tian, Kunal Gandhi, Steffen M Jugl
Publikováno v:
RMD Open, Vol 6, Iss 2 (2020)
Background/Objective The incidence of pain and/or fatigue in people with psoriatic arthritis (PsA) is associated with reduced health-related quality of life (HRQoL) and the ability to work, despite modern advanced therapeutic approaches. This real-wo
Externí odkaz:
https://doaj.org/article/ec824b5417914d5fb1388165864ab0bb
Autor:
Philip Mease, Ernest Choy, Peter Nash, Chrysostomos Kalyvas, Matthias Hunger, Luminita Pricop, Kunal K. Gandhi, Steffen M. Jugl, Howard Thom
Publikováno v:
European Journal of Rheumatology, Vol 6, Iss 3, Pp 113-121 (2019)
Externí odkaz:
https://doaj.org/article/5740df941651443383694a61827ddc82
Autor:
Iain B. McInnes, Philip J. Mease, Georg Schett, Bruce Kirkham, Vibeke Strand, Nicole Williams, Todd Fox, Luminita Pricop, Steffen M. Jugl, Kunal K. Gandhi, on behalf of the FUTURE 2 Study Group
Publikováno v:
Arthritis Research & Therapy, Vol 20, Iss 1, Pp 1-9 (2018)
Abstract Background Pain is one of the most important domains affecting health-related quality of life (HRQoL) in patients with psoriatic arthritis (PsA). Secukinumab has demonstrated rapid and sustained improvements in signs and symptoms, including
Externí odkaz:
https://doaj.org/article/3198b9481c9148638efdc4f89979257b
Autor:
K Gandhi, Emma Sullivan, Haijun Tian, S Blackburn, P.G. Conaghan, Steffen M Jugl, A. Deodhar, Vibeke Strand, Rieke Alten
Publikováno v:
Clinical Rheumatology. 38:1615-1626
Objective: There are limited data on therapy selection and switching in psoriatic arthritis (PsA). This 18 country, real-world study assessed use and switching of immunomodulatory therapy (biologic/apremilast), the extent of treatment failure and its
Autor:
K Gandhi, Vibeke Strand, Peter Nash, Brian Porter, Matthias Hunger, Howard Thom, Steffen M Jugl, Chrysostomos Kalyvas, Walter P. Maksymowych, Yusuf Yazici
Publikováno v:
European Journal of Rheumatology
Objective: Matching-adjusted indirect comparison was used to assess the comparative effectiveness of secukinumab 150 mg and adalimumab 40 mg in biologic-naive patients with ankylosing spondylitis (AS) for up to 1 year.Methods: Pooled individual patie
Autor:
Rieke Alten, Vibeke Strand, Steffen M Jugl, Philip G. Conaghan, Atul Deodhar, K Gandhi, Emma Sullivan, S Blackburn, Haijun Tian
Publikováno v:
Journal of Clinical Rheumatology
Supplemental digital content is available in the text.
Background/Objective Patients with ankylosing spondylitis (AS) experience symptoms and comorbidities that impact their health-related quality of life (HRQoL) and ability to work. This real-w
Background/Objective Patients with ankylosing spondylitis (AS) experience symptoms and comorbidities that impact their health-related quality of life (HRQoL) and ability to work. This real-w
Autor:
Josef S Smolen, Laure Gossec, K Gandhi, Philip J. Mease, Tore K Kvien, Corine Gaillez, Luminita Pricop, Steffen M Jugl, Lawrence Rasouliyan, Peter Nash, Laura C. Coates
Publikováno v:
Seminars in Arthritis and Rheumatism
Seminars in Arthritis and Rheumatism, WB Saunders, 2020, 50 (4), pp.709-718. ⟨10.1016/j.semarthrit.2020.03.015⟩
Seminars in Arthritis and Rheumatism, WB Saunders, 2020, 50 (4), pp.709-718. ⟨10.1016/j.semarthrit.2020.03.015⟩
Objectives Remission (REM) or low disease activity (LDA) states were compared in a clinical trial setting of the FUTURE 2 study (NCT01752634) using Disease Activity Index for Psoriatic Arthritis (DAPSA) and Minimal Disease Activity (MDA) composite in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8ee9a584a555d9f2a4f2fa8248f9c887
https://hal.sorbonne-universite.fr/hal-03286904/file/1-s2.0-S004901722030086X-main.pdf
https://hal.sorbonne-universite.fr/hal-03286904/file/1-s2.0-S004901722030086X-main.pdf
Autor:
P.G. Conaghan, Steffen M Jugl, Emma Sullivan, Rieke Alten, Haijun Tian, Atul Deodhar, Vibeke Strand, S Blackburn, K Gandhi
Publikováno v:
RMD Open
Background/ObjectiveThe incidence of pain and/or fatigue in people with psoriatic arthritis (PsA) is associated with reduced health-related quality of life (HRQoL) and the ability to work, despite modern advanced therapeutic approaches. This real-wor
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a457b4e66b62454e6bc3e5f55fd837a6
https://eprints.whiterose.ac.uk/162589/3/e001240.full.pdf
https://eprints.whiterose.ac.uk/162589/3/e001240.full.pdf
Autor:
S Blackburn, V. Strand, R. Alten, Steffen M Jugl, K Gandhi, Haijun Tian, E Sullivan, P.G. Conaghan, A. Deodhar
Publikováno v:
BMC Rheumatology
BMC Rheumatology, Vol 4, Iss 1, Pp 1-11 (2020)
BMC Rheumatology, Vol 4, Iss 1, Pp 1-11 (2020)
BackgroundSymptoms and comorbidities of ankylosing spondylitis (AS) considerably reduce health-related quality of life (HRQoL) and ability to work. This real-world study assessed rates of tumour necrosis factor inhibitor (TNFi) use and switching, tre
Autor:
K. Borchert, Florian Meier, Katharina Böhm, Christine König, Steffen M Jugl, Ulrich von Hinüber, Haijun Tian, Dominic Meise, Sebastian Braun, Klaus Krüger
Publikováno v:
Rheumatology International. 38:2121-2131
To compare healthcare resource utilization and costs between ankylosing spondylitis (AS) patients and a matched sample from the general population without AS covered by the German Statutory Health Insurance (SHI) system, a non-interventional retrospe